More News

06 Nov 2019 Ark Biosciences Reports Successful Completion of Phase II Proof-of-Concept Clinical Trial of Ziresovir for Treatment of Infants Hospitalized with Respiratory Syncytial Virus (RSV) Infection
06 Nov 2019 Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform
06 Nov 2019 Allogene Therapeutics and Notch Therapeutics Announce Collaboration to Research and Develop Induced Pluripotent Stem Cell (iPSC)-Derived Allogeneic Therapies for Hematologic Cancer Indications
05 Nov 2019 Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China
05 Nov 2019 BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks
01 Nov 2019 Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
01 Nov 2019 Dicerna Enters Agreement with Roche to Develop and Commercialize DCR-HBVS for the Treatment of Chronic Hepatitis B Virus (HBV) Infection
31 Oct 2019 Pandion and Astellas Announce Collaboration to Deliver Pancreas-Targeted Immunomodulators
30 Oct 2019 LEO Pharma enters into option agreement with Ubiquigent for access to novel compounds
29 Oct 2019 Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia
28 Oct 2019 Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program
28 Oct 2019 Molecular Targeting Technologies, Inc. Receives Global Rights From NIH for Integrin-Targeting Radiotherapeutics to Treat GBM and Lung Cancer
26 Oct 2019 AbbVie Announces Collaboration with Cystic Fibrosis Foundation
23 Oct 2019 Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases
23 Oct 2019 Ambrx and NovoCodex form Second Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugates
22 Oct 2019 Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics
22 Oct 2019 Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharmaceuticals Following Positive Phase 2a Proof-of-Concept Study
21 Oct 2019 Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline
21 Oct 2019 pH Pharma and Immunome Enter into Collaboration and License Agreement to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates in Oncology
21 Oct 2019 CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics
16 Oct 2019 Alexion to Acquire Achillion
16 Oct 2019 Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases
16 Oct 2019 Ipsen and Blueprint Medicines Announce Exclusive Global License Agreement to Develop and Commercialize BLU-782 for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
15 Oct 2019 CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology
11 Oct 2019 Shionogi enters into a new license agreement and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics, Inc.

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up